Treatment of myasthenia gravis
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2007/11/07
-
Indian UGC (journal)
-
Citations8
Journal Category
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Transient neonatal myasthenia gravis: refining risk estimate for infants born to women with myasthenia gravis | Journal of Perinatology |
| 5 | 2021 |
| Myasthenia gravis and pregnancy | World Journal of Obstetrics and Gynecology | 1 | 2020 | |
Clinical experiences in primary and secondary immunodeficiencies and immune-mediated conditions using Gammanorm® | Immunotherapy |
| 4 | 2016 |
| Intravenous immunoglobulin for myasthenia gravis | Cochrane Database of Systematic Reviews | 2012 | ||
| Unilateral Extended Thoracoscopic Thymectomy for Nontumoral Myasthenia Gravis—A New Standard | Seminars in Thoracic and Cardiovascular Surgery |
| 10 | 2012 |
Citations Analysis
The category
Medicine: Medicine (General) 3
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Review: Progress in the treatment of myasthenia gravis and was published in 2008. The most recent citation comes from a 2021 study titled Transient neonatal myasthenia gravis: refining risk estimate for infants born to women with myasthenia gravis. This article reached its peak citation in 2012, with 2 citations. It has been cited in 8 different journals. Among related journals, the Journal of Perinatology cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.